Physician profile
Ngwe Yin
NPI 1912344672
$1,306.08
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $319 · 2021: $696 · 2022: $145 · 2023: $26.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $26.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $26.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $195.51 | 2020-2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Abbvie INC. | $119.77 | 2019 | |
| Abbott Laboratories | $84.06 | 2021 | |
| Novo Nordisk INC | $83.95 | 2020-2022 | |
| Mannkind Corporation | $79.28 | 2021 | |
| Insulet Corporation | $76.65 | 2020-2021 | |
| Dexcom, INC. | $70.69 | 2021-2022 | |
| Corcept Therapeutics | $70.12 | 2020-2021 | |
| Sanofi-Aventis U.S. LLC | $68.81 | 2020-2022 | |
| Ipsen Biopharmaceuticals, INC | $67.11 | 2021 | |
| Ibsa Pharma INC. | $65.35 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $61.89 | 2020-2021 | |
| Lilly USA, LLC | $53.87 | 2021 | |
| Nevro Corp. | $45.46 | 2022 | |
| Eisai INC. | $31.92 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $23.14 | 2021 | |
| Alexion Pharmaceuticals, INC. | $19.48 | 2021 | |
| Medtronic, INC. | $19.45 | 2021 | |
| Lifescan, INC. | $18.65 | 2021 | |
| Becton, Dickinson and Company | $18.00 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.79 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $16.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ngwe Yin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.